FDAnews
www.fdanews.com/articles/84469-data-indicate-that-whole-inactivated-hiv-1-immunogen-induces-hiv-specific-immune-responses-in-hiv-in

DATA INDICATE THAT WHOLE-INACTIVATED HIV-1 IMMUNOGEN INDUCES HIV-SPECIFIC IMMUNE RESPONSES IN HIV-IN

February 10, 2006

The Immune Response Corporation announced today that the final results from a Phase II clinical study indicate that the Company's whole-inactivated HIV-1 immunogen induces HIV-specific immune responses in HIV-infected, antiretroviral drug-naive patients. Specifically, this original formulation product showed potential to stimulate key immunologic parameters and to stabilize the loss of CD4+ cells, which could help prolong the time before these patients need to initiate antiretroviral therapy.
INS News